It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
SAP05, a secreted effector by the obligate parasitic bacteria phytoplasma, bridges host SPL and GATA transcription factors (TFs) to the 26 S proteasome subunit RPN10 for ubiquitination-independent degradation. Here, we report the crystal structures of SAP05 in complex with SPL5, GATA18 and RPN10, which provide detailed insights into the protein-protein interactions involving SAP05. SAP05 employs two opposing lobes with an acidic path and a hydrophobic path to contact TFs and RPN10, respectively. Our crystal structures, in conjunction with mutagenesis and degradation assays, reveal that SAP05 targets plant GATAs but not animal GATAs dependent on their direct salt-bridged electrostatic interactions. Additionally, SAP05 hijacks plant RPN10 but not animal RPN10 due to structural steric hindrance and the key hydrophobic interactions. This study provides valuable molecular-level information into the modulation of host proteins to prevent insect-borne diseases.
SAP05, a secreted effector of the obligate parasitic bacteria phytoplasma, bridges host SPL and GATA transcription factors (TFs) to the 26 S proteasome subunit RPN10 for ubiquitination-independent degradation. Here, the authors report the details on how SAP05 interacts with SPL5, GATA18 and RPN10.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Tianjin Medical University, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), School of Basic Medical Sciences, Tianjin, China (GRID:grid.265021.2) (ISNI:0000 0000 9792 1228); Tianjin Medical University, Department of Biochemistry and Molecular Biology, Tianjin, China (GRID:grid.265021.2) (ISNI:0000 0000 9792 1228)
2 Tianjin Medical University, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), School of Basic Medical Sciences, Tianjin, China (GRID:grid.265021.2) (ISNI:0000 0000 9792 1228); Tianjin Medical University, Department of Biochemistry and Molecular Biology, Tianjin, China (GRID:grid.265021.2) (ISNI:0000 0000 9792 1228); Tianjin Medical University General Hospital, Department of Hepatobiliary Surgery, Tianjin, China (GRID:grid.412645.0) (ISNI:0000 0004 1757 9434)
3 Tianjin Medical University, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), School of Basic Medical Sciences, Tianjin, China (GRID:grid.265021.2) (ISNI:0000 0000 9792 1228); Tianjin Medical University, Tianjin Institute of Immunology, Department of Immunology, School of Basic Medical Sciences, Tianjin, China (GRID:grid.265021.2) (ISNI:0000 0000 9792 1228)
4 Tianjin Medical University, Department of Biochemistry and Molecular Biology, Tianjin, China (GRID:grid.265021.2) (ISNI:0000 0000 9792 1228)
5 Tianjin Medical University General Hospital, Department of Hepatobiliary Surgery, Tianjin, China (GRID:grid.412645.0) (ISNI:0000 0004 1757 9434)
6 Tianjin Medical University, Department of Pharmacology, Tianjin Key Laboratory of Inflammatory Biology, Center for Cardiovascular Diseases, Tianjin, China (GRID:grid.265021.2) (ISNI:0000 0000 9792 1228)
7 Second Hospital of Tianjin Medical University, Department of Cardiology, Tianjin Institute of Cardiology, Tianjin, China (GRID:grid.412648.d) (ISNI:0000 0004 1798 6160)
8 Tianjin Medical University, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), School of Basic Medical Sciences, Tianjin, China (GRID:grid.265021.2) (ISNI:0000 0000 9792 1228); Tianjin Medical University, Department of Biochemistry and Molecular Biology, Tianjin, China (GRID:grid.265021.2) (ISNI:0000 0000 9792 1228); Tianjin Medical University General Hospital, Department of Hepatobiliary Surgery, Tianjin, China (GRID:grid.412645.0) (ISNI:0000 0004 1757 9434); Second Hospital of Tianjin Medical University, Department of Cardiology, Tianjin Institute of Cardiology, Tianjin, China (GRID:grid.412648.d) (ISNI:0000 0004 1798 6160)